Price is showing some strong support from buyers as the ASX200 falls apart

Potential Buy Entry Alert to Watch MSB

Time Frame : Daily/Weekly

Sector : Pharmaceuticals, Biotech and Life Sciences/Healthcare

Key Stats : $957.97 Million Market Cap, VWAP 1.79, ASX Ranking 258, 4 Week Av Turnover $1,751,907, Current Turnover (Intraday as at time of alert) $644,200.

Company Overview : Mesoblast Limited (MSB) is an Australian company engaging in the development of biologic products for regenerative medicine. The key focus is on research and development of adult Mesenchymal Precursor Cells (MPCs), Mesenchymal Stem Cells (MSCs), Dental Pulp cells and Adipose cells. Its intellectual property covers applications in key markets including the United States, Europe, Japan and China.

Broker Consensus : BUY

MSB – Mesoblast Limited

MSB is showing some very strong signs that buyers are holding a higher low even as the ASX200 falls apart around it. We can see the recent run up on increased volume, was followed by a fall to 1.65 and then price has since been held up as buyers soak up any remaining selling pressure. We are now watching for a push to 1.90 and then a higher low for the buy entry setup.

Stock Code : MSB – Mesoblast Limited

Company Website : www.mesoblast.com

Current Price : 1.80

Status : On watch for potential higher low and push up through 2.20